Pricing Log in Create free account

Palvella Therapeutics, Inc. (PVLA) vs Vericel Corporation (VCEL)

Palvella Therapeutics, Inc. and Vericel Corporation are both Biotechnology companies. Vericel Corporation is the larger, with a market value of $2.7B against $2.3B — 1.2× the size. Palvella Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Vericel Corporation trades at 77.8×. Palvella Therapeutics, Inc. grew revenue faster over the last twelve months: 146.7% against 25.3%. Vericel Corporation has the higher net margin (10.3% vs 0.00%) and the higher return on invested capital (7.88% vs 0.00%). Across the 18 metrics below, Vericel Corporation leads on 15 and Palvella Therapeutics, Inc. on 3.

Valuation

Metric PVLA VCEL Biotechnology median
P/E n/m 77.80 10.26
P/S 54.15 8.11 9.18
P/B 10.38 6.84 2.05
Price to free cash flow n/m 45.40 24.81
EV/EBITDA n/m 79.14 0.65
EV/Sales 48.15 7.64 8.98
Earnings yield (3.08%) 1.29% (34.89%)
Free cash flow yield (1.43%) 2.20% (24.52%)

Profitability

Metric PVLA VCEL Biotechnology median
Gross margin 100.00% 74.47% 65.16%
Operating margin 0.00% 8.32% 0.00%
Net margin 0.00% 10.27% 0.00%
Free cash flow margin 0.00% 17.86% 0.00%
Return on equity (46.63%) 9.44% (50.12%)
Return on assets (37.70%) 6.86% (45.60%)
Return on invested capital 0.00% 7.88% 0.00%

Growth

Metric PVLA VCEL Biotechnology median
Revenue growth (TTM) 146.67% 25.30% 6.26%
EPS growth (last fiscal year) 52.62% 60.00% 29.88%
Revenue growth, 5-year CAGR 8.03% 17.34% 9.75%
Net income growth, 5-year CAGR 0.00% 41.97% 0.00%

Health

Metric PVLA VCEL Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 21.18 5.13 4.89
Net debt to EBITDA 1.50 (6.08) 1.01

Dividend

Metric PVLA VCEL Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric PVLA VCEL Biotechnology median
Market cap 2.26b 2.65b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack